The previous earnings report from Verastem (VSTM) was filled with volatility and surprises. As I outlined in my last piece, Verastem's Earnings - Is It a Buy Now?, Verastem is a company filled with … [Read more...] about Another Quarter of Growth for Verastem…Is It Enough?
On Wednesday June 12th, 2019 the MS Money Moves executive team spoke over the phone with Trevena Inc. (Nasdaq: TRVN). On the call was Trevena's President and Chief Executive Officer Carrie Bourdow … [Read more...] about Trevena Inc: A Budding Innovator Rooted In A Nobel Prize Winning Discovery
Source: MS Money Moves Week over week we see a slight improvement in the performance of the healthcare sector (represented as the XLV) and biotech industry (represented as the XBI) compared to the … [Read more...] about Biopharma Stock Watch July 22nd-26th, 2019
Press play on chart to watch IMMU trade in real-time. #IMMU look at Risk vs. Reward #Volatilitywatch by follow_the_money on TradingView.com Immunomedics Inc. (Nasdaq: IMMU) brings … [Read more...] about Immunomedics’ Risk vs. Reward
Biotechnology stocks have delivered massive returns over the last few years. Apart from improving the lives of patients, newly developed drugs have made big profits for investors in the process. A … [Read more...] about Aurinia Pharmaceuticals (NASDAQ: AUPH): Highly undervalued in light of Voclosporin’s blockbuster potential
Source: MS Money Moves July 8th-12th the Healthcare sector underperformed the greater markets as evident by the XLV and the IBB closing down -.66% and -2.06%, respectfully. The XBI stayed … [Read more...] about Biopharma Stock Watch July 15th-19th